RecruitingNot ApplicableNCT04266223

Surface Monitoring Technology to Remove The Mask - Stage 1


Sponsor

University of Sydney

Enrollment

20 participants

Start Date

Mar 28, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

A pilot-stage device feasibility study investigating a mask-free motion-monitoring patient immobilisation system for use during radiation therapy treatment of head and neck cancer (HNC). This mask-free system combines the standard radiation therapy (RT) head rest to help the patient remain still with a surface guidance detection system that uses sensors to detect and track patient movement. Patients who will have RT treatment for head and neck cancer involving an immobilisation mask will be asked to lie on the treatment couch for the normal treatment fraction time while the surface monitoring system is activated. We will then assess: i) The level of acceptance of the system by HNC patients currently being treated with RT using an immobilisation mask, and ii) The ability of the surface guidance system to monitor movement of the patients


Eligibility

Min Age: 18 Years

Inclusion Criteria7

  • A diagnosis of head and neck cancer, any stage
  • ≥ 18 years of age
  • ECOG performance status 0-2
  • Receiving radiation therapy for HNC with a thermoplastic immobilisation mask
  • Any other prior therapy allowed
  • Willing and able to comply with all study requirements
  • Must be able to read and complete questionnaires in English

Exclusion Criteria10

  • People with cognitive impairment which would preclude them from providing informed consent
  • People who are unable to speak and read English and for whom obtaining consent would be difficult.
  • Withdrawal Criteria
  • Participants may withdraw from the study at any time before, during or after participation, and do not have to provide a reason. They may do so by advising any member of the study team, research office or their treating team, by completing the withdrawal of consent form, verbally or in writing.
  • Participants may be withdrawn from the study by the principal investigator, treating physician or attending clinician if they perceive the participant is experiencing or will likely experience physical or mental harm
  • No additional study data will be collected for a participant after they withdraw from the study
  • Withdrawing participants' data will be used unless the participant specifies they no longer give permission for the data to be stored or used, however, their data will not be removed from any analysis or publication that has already occurred, or from study databases once it has been de-identified
  • Participant will be replaced if they withdraw or are withdrawn from the study prior to starting the second couch session. This will be done by recruitment of an additional participant.
  • If a couch session is ended by the researcher or participant for reasons unrelated to the study (e.g. not related to equipment failure or participant non-acceptance), the session may be rescheduled, or participant replaced.
  • Reasons for withdrawal will be reported in any outcome publications.

Interventions

DEVICEMask-free surface monitoring

Mask-free headrest and couch for patient positioning for radiation therapy combined with a surface monitoring system


Locations(1)

Blacktown Hospital

Blacktown, New South Wales, Australia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04266223


Related Trials